Changes in gut microbiota following supplementation with chitosan in adolescents with overweight or obesity: a randomized, double-blind clinical trial
- PMID: 40200345
- PMCID: PMC11978168
- DOI: 10.1186/s13098-025-01681-0
Changes in gut microbiota following supplementation with chitosan in adolescents with overweight or obesity: a randomized, double-blind clinical trial
Abstract
Background: Overweight and obesity have been associated with an altered intestinal microbiome. Recent investigations have demonstrated that fiber supplementation, including chitosan, can exert beneficial and protective effects on the composition of gut microbiota in humans diagnosed with overweight/obesity. However, there is still a great deal of heated debate regarding the impact of chitosan supplementation in overweight and obese adolescents. Therefore, the aim of this study is to clarify the effects of chitosan administration on the composition of the gut microbiome in overweight and obese adolescents.
Methods and analysis: Sixty-four overweight and obese adolescents were subjected to supplementation with 3 g of chitosan for 12 weeks. Anthropometric indices and physical activity were measured at the beginning and at the end of the intervention. After DNA extraction and purification, the quantity of bacteria in the patients' stool samples was determined by real-time polymerase chain reaction (PCR). The RCT was registered on the Iranian Registry of Clinical Trials ( www.irct.ir ) website (IRCT20091114002709 N57; registration date: 2021 - 06 - 20).
Results: Individuals who received chitosan supplementation experienced a significant decrease in the BMI z-score (P < 0.001). Administration of chitosan led to notable significant decrease in the Firmicutes (P < 0.001) populations and the ratio of Firmicutes to Bacteroidetes (P < 0.001) as well as a notable increase in the Bacteroidetes (P = 0.008) and Akkermansia (P < 0.001) populations, respectively compare to control group. Mean changes in Lactobacillus populations were marginally significant (P = 0.05). Chitosan administration did not alter the composition in Bifidobacterium populations (P = 0.97).
Conclusion: The present study demonstrates beneficial effects of chitosan administration on some bacterial species associated with overweight and obesity in adolescents. Further research is needed to confirm our findings and clarify the impact of this intervention on the Lactobacillus population in the gut.
Keywords: Adolescence; Chitosan; Gut microbiome; Obesity.
© 2025. The Author(s).
Conflict of interest statement
Declarations. Ethics approval and consent to participate: This study was approved by the research council and ethics committee of Iran University of Medical Sciences, Tehran, Iran (NO: IR.IUMS.REC.1400.104). The study has been registered in IRCT (IRCT20091114002709 N57; registration date: 2021 - 06 - 20). Consent for publication: An informed consent was obtained from all the individuals included in the study. All participants agreed to publish. Competing interests: The authors declare no competing interests.
Similar articles
-
The effects of chitosan supplementation on anthropometric indicators of obesity, lipid and glycemic profiles, and appetite-regulated hormones in adolescents with overweight or obesity: a randomized, double-blind clinical trial.BMC Pediatr. 2022 Sep 5;22(1):527. doi: 10.1186/s12887-022-03590-x. BMC Pediatr. 2022. PMID: 36064382 Free PMC article. Clinical Trial.
-
Effects of synbiotic supplementation on intestinal microbiota composition in children and adolescents with exogenous obesity: (Probesity-2 trial).Gut Pathog. 2023 Jul 21;15(1):36. doi: 10.1186/s13099-023-00563-y. Gut Pathog. 2023. PMID: 37474971 Free PMC article.
-
The effects of synbiotic and/or vitamin D supplementation on gut-muscle axis in overweight and obese women: a study protocol for a double-blind, randomized, placebo-controlled trial.Trials. 2022 Aug 4;23(1):631. doi: 10.1186/s13063-022-06598-x. Trials. 2022. PMID: 35927757 Free PMC article.
-
Effect of Probiotic Supplementation on Intestinal Permeability in Overweight and Obesity: A Systematic Review of Randomized Controlled Trials and Animal Studies.Adv Nutr. 2024 Jan;15(1):100162. doi: 10.1016/j.advnut.2023.100162. Epub 2023 Dec 8. Adv Nutr. 2024. PMID: 38072119 Free PMC article. Review.
-
Effects of pro-/synbiotic supplementation on anthropometric and metabolic indices in overweight or obese children and adolescents: A systematic review and meta-analysis.Complement Ther Med. 2019 Jun;44:269-276. doi: 10.1016/j.ctim.2019.05.008. Epub 2019 May 8. Complement Ther Med. 2019. PMID: 31126565
Cited by
-
The effect of Akkermansia in patients with pregnancy induced hypertension.BMC Microbiol. 2025 Jul 2;25(1):386. doi: 10.1186/s12866-025-04087-0. BMC Microbiol. 2025. PMID: 40604383 Free PMC article.
References
-
- Berhane Y, Canavan CR, Darling AM, Sudfeld CR, Vuai S, Adanu R, et al. The age of opportunity: prevalence of key risk factors among adolescents 10–19 years of age in nine communities in sub-Saharan Africa. Tropical Med Int Health. 2020;25(1):15–32. - PubMed
-
- Fryar CD, Carroll MD, Ogden CL. Prevalence of overweight, obesity, and severe obesity among children and adolescents aged 2–19 years: United States, 1963–1965 through 2015–2016. 2018.
-
- Flegal KM, Wei R, Ogden C. Weight-for-stature compared with body mass index–for-age growth charts for the United States from the centers for disease control and prevention. Am J Clin Nutr. 2002;75(4):761–6. - PubMed
LinkOut - more resources
Full Text Sources